The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Gut Microbes Activate T Cells Causing Autoimmune Eye Disease

Gut Microbes Activate T Cells Causing Autoimmune Eye Disease

August 21, 2015 • By Will Boggs, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

NEW YORK (Reuters Health)—Commensal microbes in the gut can activate retina-specific T cells that go on to cause autoimmune uveitis in a mouse model, researchers report.

You Might Also Like
  • The Role of T Cells in Celiac Disease
  • Lacrimal & Tear Fluid Yield Clues to Dry Eye Disease
  • Optical Workings: Specialists Must Communicate to Treat Eye Disease

“These findings allow us to understand the biological basis for the disease,” lead author of the study, Dr. Rachel Caspi from National Eye Institute at the NIH in Bethesda, Md., wrote via email to Reuters Health. “The findings should in no way be interpreted that a patient can pop a probiotic pill and their disease will improve, or that they should start taking antibiotics to eliminate commensal bacteria.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In order to enter the eye, pathogenic T cells must first be activated, but the target antigens are sequestered in the eye and are not expressed in the periphery. A major unresolved question has been where such retina-specific T cells become activated.

Knowing that T cells can be activated by microbial components in the gut environment, Dr. Caspi’s team used the R161H mouse model of autoimmune uveitis to study natural triggers of the disease.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

They found that spontaneous uveitis in these mice is associated with enhancement of IL-17 producing T cells in the gut and that elimination of commensals not only attenuates uveitis but also reduces activation of those T cells in the intestine.

Moreover, activation of these T cells is independent of endogenous interphotoreceptor retinoid-binding protein (IRBP) expression. Rather, the retina-specific T cells in the intestine are activated by signals derived from intestinal microbiota.

Gut microbe-rich protein extracts contain all the stimuli needed to make retina-specific T cells capable of breaching the intact blood-retinal barrier and causing uveitis, according to the report published online Aug. 18 in Immunity.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“Our data uncover for the first time that lymphocytes which recognize self proteins (in our case retinal proteins) can be activated in the intestine through their specific receptors by the commensal bacteria to cause inflammation in the eye,” Dr. Caspi said. “We believe that this could be an under-appreciated mechanism that might underlie other autoimmune diseases.”

Filed Under: Conditions, Systemic Inflammatory Syndromes Tagged With: gut microbe, Inflammatory Eye Disease, retina, T cell, Uveitis

You Might Also Like:
  • The Role of T Cells in Celiac Disease
  • Lacrimal & Tear Fluid Yield Clues to Dry Eye Disease
  • Optical Workings: Specialists Must Communicate to Treat Eye Disease
  • Innate Immune Response Enters Center Stage for Inflammatory Eye Disease

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)